The table below shows Medpace Holdings, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$713.22M
$608.82M
$433.37M
$388.05M
$263.33M
$258.68M
Capital expenditure
$31.36M
$36.55M
$36.65M
$36.88M
$28.27M
$31.34M
Investing cash flow
-$31.14M
-$28.31M
-$34.63M
-$38.74M
-$31.36M
-$31.21M
Dividends paid
-
-
-
-
-
MEDP operating cash flow (10-K history)
Medpace Holdings, Inc. reported operating cash flow of $713.22M for fiscal year 2025. That is up 17.1% from $608.82M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $91.73M (FY 2016) to $713.22M. Figures come from the company's audited annual reports as filed with the SEC.
